Search research articles
Contact Us
Filters
Showing results (311-320 of 328) with videos related to
Page
of 33
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trial
J Guo, R D Carvajal, R Dummer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 8, 2014
Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC study
D Schadendorf, M M Amonkar, M Milhem, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 8, 2021
EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours
E Le Rhun, M Guckenberger, M Smits, et al.
The British Journal of Dermatology
|
January 17, 2021
A multicentre study of naevus-associated melanoma vs. de novo melanoma, tumour thickness and body site differences
C Dessinioti, A C Geller, A Stergiopoulou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 30, 2019
Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma
Y J L Jansen, E A Rozeman, R Mason, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 11, 2020
Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy<sup>☆</sup>
C N Owen, A N Shoushtari, D Chauhan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 16, 2024
Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
T Amaral, M Ottaviano, A Arance, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 16, 2020
Which medical disciplines diagnose and treat melanoma in Europe in 2019? A survey of experts from melanoma centres in 27 European countries
L Kandolf-Sekulovic, K Peris, A Stratigos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 9, 2020
ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee
O Michielin, A van Akkooi, P Lorigan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 9, 2020
ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee
U Keilholz, P A Ascierto, R Dummer, et al.
Page
of 33
Search research articles
Search
Showing results (311-320 of 328) with videos related to
Sort By:
Page
of 33
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trial
J Guo, R D Carvajal, R Dummer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 8, 2014
Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC study
D Schadendorf, M M Amonkar, M Milhem, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 8, 2021
EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours
E Le Rhun, M Guckenberger, M Smits, et al.
The British Journal of Dermatology
|
January 17, 2021
A multicentre study of naevus-associated melanoma vs. de novo melanoma, tumour thickness and body site differences
C Dessinioti, A C Geller, A Stergiopoulou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 30, 2019
Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma
Y J L Jansen, E A Rozeman, R Mason, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 11, 2020
Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy<sup>☆</sup>
C N Owen, A N Shoushtari, D Chauhan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 16, 2024
Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
T Amaral, M Ottaviano, A Arance, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 16, 2020
Which medical disciplines diagnose and treat melanoma in Europe in 2019? A survey of experts from melanoma centres in 27 European countries
L Kandolf-Sekulovic, K Peris, A Stratigos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 9, 2020
ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee
O Michielin, A van Akkooi, P Lorigan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 9, 2020
ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee
U Keilholz, P A Ascierto, R Dummer, et al.
Page
of 33